WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 53.6% in April

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 11,358 shares, a decline of 53.6% from the April 15th total of 24,485 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 77,773 shares, the days-to-cover ratio is presently 0.1 days.

WuXi Biologics (Cayman) Stock Performance

OTCMKTS:WXXWY opened at $8.50 on Friday. WuXi Biologics has a 52 week low of $5.81 and a 52 week high of $11.21. The stock’s fifty day moving average is $8.77 and its two-hundred day moving average is $9.01.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.